Cargando…
Diclofenac in the treatment of pain in patients with rheumatic diseases
Diclofenac, a phenylacetic acid derivative, is a drug demonstrating high efficacy after oral administration in the treatment of pain and physical disability in rheumatic diseases. In view of the adverse effects associated with using diclofenac, it is necessary to consider all known drug safety infor...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052370/ https://www.ncbi.nlm.nih.gov/pubmed/30042605 http://dx.doi.org/10.5114/reum.2018.76816 |
_version_ | 1783340640288899072 |
---|---|
author | Kołodziejska, Justyna Kołodziejczyk, Michał |
author_facet | Kołodziejska, Justyna Kołodziejczyk, Michał |
author_sort | Kołodziejska, Justyna |
collection | PubMed |
description | Diclofenac, a phenylacetic acid derivative, is a drug demonstrating high efficacy after oral administration in the treatment of pain and physical disability in rheumatic diseases. In view of the adverse effects associated with using diclofenac, it is necessary to consider all known drug safety information before the drug is selected for therapy and the dosage regimen is set for individual patients. Selecting an oral dosage form with specific properties determined by excipients is a method to improve the availability of the drug substance and, at the same time, minimize adverse drug reactions. An alternative to tablet or capsule dosage forms is diclofenac application to the skin. The proven efficacy of this method is further improved through the use of transdermal penetration enhancers and vehicle ingredients which provide dosage forms with specific physical properties. |
format | Online Article Text |
id | pubmed-6052370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie |
record_format | MEDLINE/PubMed |
spelling | pubmed-60523702018-07-24 Diclofenac in the treatment of pain in patients with rheumatic diseases Kołodziejska, Justyna Kołodziejczyk, Michał Reumatologia Review Paper Diclofenac, a phenylacetic acid derivative, is a drug demonstrating high efficacy after oral administration in the treatment of pain and physical disability in rheumatic diseases. In view of the adverse effects associated with using diclofenac, it is necessary to consider all known drug safety information before the drug is selected for therapy and the dosage regimen is set for individual patients. Selecting an oral dosage form with specific properties determined by excipients is a method to improve the availability of the drug substance and, at the same time, minimize adverse drug reactions. An alternative to tablet or capsule dosage forms is diclofenac application to the skin. The proven efficacy of this method is further improved through the use of transdermal penetration enhancers and vehicle ingredients which provide dosage forms with specific physical properties. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018-06-30 2018 /pmc/articles/PMC6052370/ /pubmed/30042605 http://dx.doi.org/10.5114/reum.2018.76816 Text en Copyright: © 2018 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Review Paper Kołodziejska, Justyna Kołodziejczyk, Michał Diclofenac in the treatment of pain in patients with rheumatic diseases |
title | Diclofenac in the treatment of pain in patients with rheumatic diseases |
title_full | Diclofenac in the treatment of pain in patients with rheumatic diseases |
title_fullStr | Diclofenac in the treatment of pain in patients with rheumatic diseases |
title_full_unstemmed | Diclofenac in the treatment of pain in patients with rheumatic diseases |
title_short | Diclofenac in the treatment of pain in patients with rheumatic diseases |
title_sort | diclofenac in the treatment of pain in patients with rheumatic diseases |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052370/ https://www.ncbi.nlm.nih.gov/pubmed/30042605 http://dx.doi.org/10.5114/reum.2018.76816 |
work_keys_str_mv | AT kołodziejskajustyna diclofenacinthetreatmentofpaininpatientswithrheumaticdiseases AT kołodziejczykmichał diclofenacinthetreatmentofpaininpatientswithrheumaticdiseases |